Why Ghanaian Healthcare Data May Be Valuable to the United States

Ghana healthcare data has become more than a medical issue. It is now part of a larger debate about data ownership, national sovereignty, artificial intelligence, pharmaceutical research, and Africa’s demographic future.

Ghana recently rejected a proposed U.S. health agreement after concerns were raised about access to sensitive health data. The story matters because Africa is projected to drive much of the world’s population growth over the rest of this century. If Africa becomes one of the largest sources of future health data, then control over that data becomes a strategic asset.

This does not mean every foreign health partnership is bad. U.S. support has helped many countries fight HIV, malaria, tuberculosis, maternal health risks, and disease outbreaks. The real question is narrower and more important: who owns the data, who controls access, who profits from it, and what protections exist for ordinary Ghanaians?

Why Africa’s Population Growth Changes the Value of Health Data

Africa is expected to lead global population growth for the rest of this century. The United Nations Economic Commission for Africa reported that Africa’s population passed 1.5 billion in 2024 and is projected to reach about 2.5 billion by 2050. That would increase Africa’s share of the world population to roughly 28% by 2050.

Other long-range demographic projections show Africa’s share of the global population rising further by 2100, some models suggest nearly 40%. That matters because the future of healthcare research, disease surveillance, pharmaceutical markets, and health AI will depend heavily on African populations.

In plain English, the next century of global health will not be built only from U.S., European, or Asian data. It will increasingly depend on African data. For example, a 2024 UNICEF report estimates that Africa will be home to 2 in 5 children (40%) globally by 2050. This means long-term longitudinal health studies will need African participants to be relevant. Pharmaceutical companies developing treatments for childhood diseases, metabolic disorders, or vaccine responses cannot ignore African genetic and environmental diversity without producing biased or ineffective products.

Why Ghana Healthcare Data Could Be Valuable

Ghana’s healthcare data could be valuable because it sits at the intersection of population growth, disease surveillance, digital health, pharmaceutical research, and geopolitical influence. Ghana, in particular, offers several unique advantages: political stability, English as the official language, a growing digital infrastructure (including the Ghana Card national ID system), and a relatively advanced health information management system compared to many low-income countries.

This is why the debate should not be reduced to “aid good” or “aid bad.” Healthcare data has real humanitarian value, but it also has commercial, political, and strategic value. The challenge is separating legitimate collaboration from extractive practices.

What the United States Could Do With Ghana Healthcare Data

The United States government, its research universities, pharmaceutical partners, and technology companies could use Ghanaian health data in several important ways. Some are clearly beneficial; others raise concerns without proper safeguards.

1. Improve Disease Surveillance and Global Health Security

The strongest public-interest argument is disease prevention. If health data is shared responsibly, it can help detect outbreaks earlier, track disease movement, and improve response planning. For the United States, that matters because infectious diseases do not respect borders.

Better surveillance in Ghana could help identify trends in malaria, tuberculosis, HIV, respiratory illness, maternal health, and emerging infectious diseases before they become larger regional or global problems. For example, during the 2014 West African Ebola outbreak, late detection cost thousands of lives. Early warning systems powered by real-time data sharing could prevent similar tragedies. The U.S. Centers for Disease Control and Prevention (CDC) has global surveillance programs, and Ghanaian data would strengthen those networks.

2. Train Health AI Systems

Healthcare is moving toward artificial intelligence. AI tools need large datasets to predict disease patterns, recommend treatments, detect risk, and manage health systems. However, most existing medical AI models are trained on data from North America, Europe, and China. They perform poorly when applied to African populations because of differences in genetics, disease prevalence, diet, environment, and healthcare delivery.

If U.S. institutions can access structured Ghanaian health data, that data could be used to train AI models specifically for African health conditions. That could be genuinely beneficial if Ghana has ownership and benefit-sharing rights, for instance, if Ghanaian hospitals receive free or low-cost access to the resulting AI tools. It becomes dangerous if foreign institutions build profitable proprietary systems from Ghanaian data while Ghana remains dependent on imported tools it cannot afford.

3. Support Pharmaceutical Research and Clinical Trials

Pharmaceutical and biotech companies need diverse health data. Historically, global medical research has often underrepresented African populations. According to a 2025 World Economic Forum analysis citing WHO data, Africa bears 25% of the global disease burden yet hosted just 1.1% of global clinical trials in 2023. Ghanaian data could help researchers better understand how diseases appear in African populations and how treatments perform across different genetic and environmental backgrounds.

Already, Ghana has been a site for several major vaccine and drug trials, including malaria vaccines and COVID-19 therapeutics. The upside is better medicine and potentially lower prices for Ghana if benefit-sharing includes affordable access. The risk is extraction, if Ghanaian data helps create profitable drugs, Ghana should not be left buying those same products later at prices ordinary citizens cannot afford.

4. Shape Health Policy and Funding Priorities

Data controls the story. Whoever controls health data can influence which problems are seen as urgent, which programs get funded, and which interventions are considered successful. Major global health funders, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Global Fund, the Bill & Melinda Gates Foundation, rely heavily on data from partner countries to make decisions.

That influence can be helpful when aligned with Ghana’s national priorities. It can become a problem if Ghana’s health agenda is quietly shaped around donor priorities instead of the needs of Ghanaian patients. For example, vertical disease programs (HIV, malaria, TB) have historically received far more funding than primary care or non-communicable disease treatment, partly because data systems made vertical programs easier to measure.

What Could Go Wrong?

The concern is not that health data should never be shared. The concern is that health data can be misused, overused, commercialized, or transferred without enough protection. Below are specific, documented risks, some of which have occurred in other African countries.

1. Ghana Could Lose Control Over Sensitive National Data

If too many foreign entities can access Ghana’s data without Ghana’s prior approval, Ghana loses practical control even if it still claims legal ownership. That is why data governance language matters. A bad agreement may allow access not only to de-identified patient records but also to metadata, dashboards, system tools, or analytics without enough Ghanaian oversight. Once data is copied, transferred, or integrated into foreign systems, reversing that access can be difficult — even legally impossible if the data has been incorporated into larger commercial datasets.

A cautionary tale: In Kenya, a court suspended implementation of a U.S.-Kenya bilateral health deal after a consumer protection group challenged it over data-sharing and national sovereignty concerns. The case highlighted how weak oversight can lead to unintentional data transfers.

2. Data Could Be Used for Profit Without Fair Benefit Sharing

This is one of the biggest risks. Ghanaian data could help foreign institutions develop drugs, AI platforms, insurance models, research products, or analytics tools. Those tools may then be sold globally — including back to Ghana, at prices that reflect their commercial value. If Ghana receives only short-term aid while foreign companies receive long-term commercial value, the deal becomes unequal.

Benefit-sharing is not theoretical. The World Health Organization’s proposed Pathogen Access and Benefit-Sharing (PABS) system aims to ensure that countries sharing pathogen samples and genetic data get fair access to resulting vaccines, tests, and treatments. Ghana should demand similar or better terms in any health data agreement.

3. Genetic Data Could Be Misused

Genetic and biological data require special caution. Once genetic information leaves Ghana, it could be used in ways patients never expected. Possible risks include:

• Unauthorized research beyond the original consent (e.g., using blood samples for genetic studies on traits unrelated to the original disease)
• Weak consent procedures that fail to explain secondary uses in plain language
• Genetic profiling that could stigmatize certain ethnic groups or communities
• Commercial use without compensation, such as patenting genes or developing ancestry tests
• Future discrimination by insurers, employers, or other actors if protections are weak or if data is re-identified

The Havasupai tribe in the United States famously sued Arizona State University after blood samples given for diabetes research were used for schizophrenia, migration, and inbreeding studies without consent. The university paid $700,000 and returned the samples. Ghana must not repeat that mistake.

4. Foreign Systems Could Create Digital Dependency

If Ghana relies on foreign-built systems to store, analyze, and interpret its own health data, Ghana may become dependent on outside vendors for critical public health decisions. That would weaken domestic capacity. Ghana needs local data scientists, health informatics specialists, cybersecurity teams, legal experts, and public health analysts who can manage national data infrastructure from inside Ghana.

Dependency also creates recurring costs. Foreign software licenses, cloud storage fees, and consulting contracts drain national budgets. Several African countries have seen donor-funded health information systems collapse after the initial grant ended because local staff lacked training and source code was not transferred.

5. Health Data Could Become Strategic Intelligence

Health data can reveal more than medical conditions. It can show where a country is vulnerable. For example, health data can reveal:

• Regions with weak hospitals or no surgical capacity
• Areas vulnerable to disease outbreaks due to low vaccination coverage
• Drug supply shortages in specific districts
• Public health system weaknesses, including staffing gaps
• Population-level risk patterns (e.g., malnutrition hotspots)
• Gaps in state capacity to respond to emergencies

That information can help humanitarian planning, but it can also be strategically sensitive during political instability, conflict, or even trade negotiations. A foreign power armed with detailed maps of Ghana’s health vulnerabilities could use that information in non-health contexts.

The Balanced View: Aid Can Help, But Terms Matter

It would be a mistake to say Ghana should reject every U.S. health partnership. U.S. health funding has supported major programs across Africa for years, especially in HIV, malaria, tuberculosis, maternal health, and disease preparedness. PEPFAR alone has saved an estimated 25 million lives since 2003, and Ghana has benefited from U.S.-funded antiretroviral therapy, bed net distribution, and laboratory strengthening. In 2024, the U.S. provided $219 million in total assistance to Ghana, including $96 million for health programs.

It would also be a mistake to treat data access as a minor administrative detail. Data is now infrastructure. It is also a form of power. The same data that helps track a malaria outbreak can also be used to train a commercial AI algorithm or to map a country’s health vulnerabilities for non-humanitarian purposes.

The smart position is not anti-American or anti-aid. The smart position is pro-Ghanaian sovereignty, pro-patient privacy, and pro-fair partnership. Ghana can and should cooperate with the United States and other partners — but only on terms that protect Ghana’s long-term interests, build domestic capacity, and ensure that the people whose data is being used actually benefit.

What Ghana Should Demand in Any Health Data Agreement

If Ghana enters a health data agreement with the United States or any other foreign partner, the agreement should protect Ghana’s long-term interests. Below is a checklist of non-negotiable protections, informed by international best practices and the African Union’s Data Policy Framework.

Ghana already has a Data Protection Act, 2012 (Act 843), which established the Data Protection Commission and regulates the processing of personal data. Any international health agreement should be measured against that legal framework, not treated as separate from it. The Commission should have the power to approve or reject any data-sharing agreement involving Ghanaian health records. Furthermore, Ghana should consider updating Act 843 to explicitly address genetic data, cross-border data flows, and benefit-sharing — areas where the original law is vague.

What Other African Countries Are Doing

Ghana is not alone in facing these questions. Several other African nations have already taken steps to protect health data sovereignty, and their experiences offer useful lessons.

South Africa

South Africa’s Protection of Personal Information Act (POPIA), fully effective since 2021, imposes strict conditions on cross-border data transfers under Section 72, which can limit how and when personal health data leaves the country.

Kenya

Kenya’s Data Protection Act (2019) established an Office of the Data Protection Commissioner and requires data controllers to register. In a notable case, Kenya’s High Court temporarily suspended a U.S.-Kenya health funding agreement pending a hearing on data privacy concerns, demonstrating the importance of judicial oversight in health data agreements.

Rwanda

Rwanda has taken a different approach by actively pursuing health and pharmaceutical partnerships while maintaining strong government oversight. Detailed public terms for many health data arrangements remain limited, so Ghana should treat Rwanda as a cooperation model, not as proof that every partnership includes benefit-sharing.

African Union Continental Framework

The African Union has adopted the AU Data Policy Framework (2022), which encourages member states to enact harmonized data protection laws, require cross-border data transfer safeguards, and promote African ownership of data generated on the continent. The African Union Convention on Cybersecurity and Personal Data Protection (Malabo Convention) entered into force on June 8, 2023. Ghana ratified the Malabo Convention on June 3, 2019 and is a full state party. Ghana should ensure its health data agreements align with these continental standards to avoid being picked off by bilateral deals that undermine African solidarity.

Technical and Legal Safeguards: A Deeper Dive

Protecting health data is not just about signing good contracts. It requires technical infrastructure, legal enforcement, and institutional capacity. Here are the key areas Ghana should invest in, regardless of specific foreign partnerships.

Data Localization vs. Cloud Storage

Data localization means storing Ghanaian health data on servers physically located in Ghana. This makes it easier to apply Ghanaian law, conduct audits, and prevent foreign subpoenas or intelligence collection. However, local servers require investment in data centers, backup power, cooling, and cybersecurity. A pragmatic middle ground is “mirrored” storage — keeping a full copy in Ghana while allowing a foreign partner to access a synchronized copy for specific, time-limited purposes under strict controls.

De-Identification and Anonymization Standards

De-identification removes direct identifiers (names, ID numbers, addresses). Anonymization goes further, making re-identification mathematically improbable. Ghana should require that any data shared internationally be fully anonymized, not just de-identified, because de-identified data can often be re-identified by linking it with other datasets. Independent verification of anonymization methods should be mandatory.

Audit Logging and Blockchain Verification

Every access to Ghanaian health data should be logged — who accessed it, when, from where, and for what purpose. Those logs should be immutable (e.g., using blockchain or similar tamper-proof technology) and accessible to Ghana’s Data Protection Commission at any time. Without audit logs, Ghana has no way to know if its data has been misused.

Building Local Expertise

Data protection clauses are only as good as the people enforcing them. Ghana needs more trained data protection officers, health informaticians, cybersecurity analysts, and digital rights lawyers. The Data Protection Commission is currently underfunded and understaffed. Parliament should allocate dedicated resources for health data governance, possibly funded by a small percentage of any international health data agreement.

Why This Matters for Ghanaians and the Diaspora

For Ghanaians at home, this is about privacy, national planning, and whether the health system serves local people first. If Ghanaian health data is commercialized without benefit-sharing, it is ordinary patients — not foreign companies — who lose. If the data is used to train AI models that Ghana cannot afford, the digital divide widens.

For Ghanaians abroad and members of the diaspora considering relocation, it matters because digital systems are becoming part of everyday life in Ghana. National ID systems (Ghana Card), health records, mobile money, immigration databases, and digital public services are all becoming connected pieces of the same governance puzzle. Data governance in health will set precedents for data governance in finance, education, and voting.

Diaspora Ghanaians who return to live or invest may also be affected directly. Their health data — including genetic information — could become part of national datasets shared with foreign partners. They have a right to know what protections exist and whether their data might be used for commercial purposes. Ghana should consider whether returning citizens should have additional consent rights or opt-out choices given that they may have lived under different privacy regimes.

If Ghana gets data governance right, it can become a model for African digital sovereignty — attracting diaspora talent and investment that values ethical data practices. If it gets it wrong, it may give away one of the most valuable assets of the next century before most people understand what happened.

Bottom Line

Ghana healthcare data is valuable because Africa is becoming central to the future of global population growth, global health research, disease surveillance, AI development, and pharmaceutical innovation. Ghana sits at a crossroads: it can either negotiate from a position of strength, insisting on fair terms, data localization, benefit-sharing, and robust legal protections — or it can accept one-sided deals that prioritize short-term aid over long-term sovereignty.

The United States has legitimate reasons to want strong health partnerships with Ghana. Better data can help prevent disease, improve treatment, and protect global health. But Ghana also has legitimate reasons to be cautious. Health data can be commercialized, politicized, transferred, misused, or turned into a tool of dependency.

The core issue is not whether Ghana should cooperate with the United States. The core issue is whether Ghana can cooperate without surrendering control over one of its most important future assets. With strong legal frameworks, technical capacity, and political will, Ghana can have both partnership and sovereignty. The next agreement Ghana signs — or rejects — will set a precedent for a generation.

Frequently Asked Questions

1. Did Ghana completely reject all U.S. health cooperation?
No. Ghana rejected a specific proposed agreement over concerns about data access provisions. Reuters reported the deal was worth about $109 million over five years; AP described a broader $300 million agreement. Ongoing cooperation on disease outbreaks, HIV treatment, and malaria prevention continues under existing frameworks. The rejection was about the terms of a future deal, not an end to all cooperation.

2. Is Ghanaian law strong enough to protect health data today?
The Data Protection Act (Act 843) provides a good foundation, but it has gaps. It was passed in 2012, before the current wave of AI and genetic data commercialization. It lacks explicit provisions on cross-border data transfers, benefit-sharing, and genetic data. The Data Protection Commission is also under-resourced. Legal reform and institutional investment are needed.

3. Can U.S. companies or researchers access Ghanaian health data without the government’s permission?
Not legally if the data is held by public institutions. However, foreign researchers can partner with Ghanaian hospitals or universities on a case-by-case basis, subject to ethical review and institutional approvals. The concern is about broad, programmatic access through a high-level government agreement — which is what Ghana reportedly rejected.

4. Would data localization slow down disease surveillance or research collaboration?
Potentially, but manageable. Local copies can be synchronized with foreign partners under strict controls and time limits. The extra friction is a feature, not a bug — it forces accountability and consent. Many countries with stronger data protection laws (Germany, Canada, South Africa) use localization without crippling research.

5. What can an ordinary Ghanaian do to protect their health data?
Ask questions. When you visit a hospital or clinic, request to see their data privacy policy. Ask whether your data will be shared internationally and for what purpose. Support civil society organizations advocating for stronger data protection. And contact the Data Protection Commission if you believe your rights have been violated.

Sources

• Associated Press: Ghana rejects U.S. health deal over data sharing concerns
• Reuters: Ghana rejects proposed U.S. health aid deal, citing data concerns
• Reuters: Kenyan court suspends health pact with US to hear data privacy case
• UNECA: Africa’s population crosses 1.5 billion
• UNICEF: Africa will be home to 2 in 5 children by 2050
• World Economic Forum: Clinical trials are key to improving medicines access in Africa (citing WHO data)
• NHIS Ghana: Active membership hits 56% coverage (November 2025)
• AMA Journal of Ethics: Genetic Research among the Havasupai – A Cautionary Tale
• African Union Data Policy Framework (2022)
• African Union: Malabo Convention (entered into force June 8, 2023)
• PEPFAR: 25 million lives saved
• Genomic research in Africa: underrepresentation and opportunities (2022)
• Ghana Data Protection Act, 2012 Act 843